Femme et Homme
- | Pays :
- France
- | Organes : -
- | Spécialités : -
Extrait
To compare the efficacy of BF2.649 over placebo (12 week Double-Blind Phase) and assess the long term safety and the efficacy maintenance(9 months Open-Label Extension Phase) of BF2.649 in the improvement of excessive daytime sleepiness in patients diagnosed with Parkinson's Disease.
Critère d'inclusion
- Parkinson's disease